MA22978A1 - Nouvelles compositions a base de derives de nomegestrol et leurs procedes d'obtention. - Google Patents

Nouvelles compositions a base de derives de nomegestrol et leurs procedes d'obtention.

Info

Publication number
MA22978A1
MA22978A1 MA23291A MA23291A MA22978A1 MA 22978 A1 MA22978 A1 MA 22978A1 MA 23291 A MA23291 A MA 23291A MA 23291 A MA23291 A MA 23291A MA 22978 A1 MA22978 A1 MA 22978A1
Authority
MA
Morocco
Prior art keywords
nomegestrol
derivatives
processes
compositions based
novel compositions
Prior art date
Application number
MA23291A
Other languages
English (en)
French (fr)
Inventor
Michel Lanquetin
Jacques Paris
Jean Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of MA22978A1 publication Critical patent/MA22978A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
MA23291A 1992-09-21 1993-09-20 Nouvelles compositions a base de derives de nomegestrol et leurs procedes d'obtention. MA22978A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Publications (1)

Publication Number Publication Date
MA22978A1 true MA22978A1 (fr) 1994-04-01

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23291A MA22978A1 (fr) 1992-09-21 1993-09-20 Nouvelles compositions a base de derives de nomegestrol et leurs procedes d'obtention.

Country Status (31)

Country Link
US (1) US5565443A (enExample)
EP (1) EP0613372B1 (enExample)
JP (1) JPH08506318A (enExample)
KR (1) KR100255700B1 (enExample)
CN (1) CN1095667C (enExample)
AP (1) AP497A (enExample)
AT (1) ATE198275T1 (enExample)
AU (1) AU683423B2 (enExample)
BG (1) BG62317B1 (enExample)
BR (1) BR9305642A (enExample)
CA (1) CA2122827A1 (enExample)
CZ (1) CZ284806B6 (enExample)
DE (1) DE69329790D1 (enExample)
DZ (1) DZ1717A1 (enExample)
EC (1) ECSP930986A (enExample)
FI (1) FI942272A0 (enExample)
FR (1) FR2695826B1 (enExample)
HU (1) HUT67044A (enExample)
IL (1) IL107039A (enExample)
MA (1) MA22978A1 (enExample)
NO (1) NO306238B1 (enExample)
OA (1) OA09924A (enExample)
PL (1) PL176120B1 (enExample)
RO (1) RO115783B1 (enExample)
RU (1) RU2120797C1 (enExample)
SK (1) SK54694A3 (enExample)
TN (1) TNSN93104A1 (enExample)
TW (1) TW381024B (enExample)
WO (1) WO1994006437A1 (enExample)
YU (1) YU60493A (enExample)
ZA (1) ZA936964B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
GB2355728A (en) * 1999-10-27 2001-05-02 Anson Medical Ltd Tubular medical implants and methods of manufacture
CA2418135C (en) 2000-08-03 2011-09-20 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ES2385030T3 (es) 2001-06-29 2012-07-17 Medgraft Microtech, Inc. Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
SI1610791T1 (sl) * 2003-03-31 2011-05-31 Titan Pharmaceuticals Inc Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista
US20050031668A1 (en) * 2003-05-30 2005-02-10 Patel Rajesh A. Implantable polymeric device for sustained release of nalmefene
CA2538856C (en) 2003-10-10 2010-06-29 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
FR2904213B1 (fr) * 2006-07-27 2008-10-10 Creaspine Soc Par Actions Simp Implant intervertebral destine a la fusion osseuse
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
US12582767B2 (en) 2021-12-30 2026-03-24 Taiyo Weber Compressible, minimally invasive implants and related systems and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
AP497A (en) 1996-05-28
YU60493A (sh) 1997-01-08
CZ116494A3 (en) 1995-03-15
PL176120B1 (pl) 1999-04-30
HU9401395D0 (en) 1994-08-29
IL107039A0 (en) 1993-12-28
EP0613372A1 (fr) 1994-09-07
CN1094284A (zh) 1994-11-02
RU2120797C1 (ru) 1998-10-27
US5565443A (en) 1996-10-15
WO1994006437A1 (fr) 1994-03-31
TNSN93104A1 (fr) 1994-03-17
FI942272A7 (fi) 1994-05-16
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
ZA936964B (en) 1994-04-14
BG98776A (bg) 1995-02-28
BR9305642A (pt) 1996-01-09
SK54694A3 (en) 1994-10-05
CZ284806B6 (cs) 1999-03-17
ECSP930986A (es) 1994-04-12
AP9300576A0 (enExample) 1993-10-31
HUT67044A (en) 1995-01-30
NO941900D0 (no) 1994-05-20
NO306238B1 (no) 1999-10-11
OA09924A (fr) 1994-09-15
RO115783B1 (ro) 2000-06-30
ATE198275T1 (de) 2001-01-15
AU4822993A (en) 1994-04-12
FI942272L (fi) 1994-05-16
KR100255700B1 (ko) 2000-08-01
FR2695826B1 (fr) 1995-01-06
IL107039A (en) 1999-01-26
CN1095667C (zh) 2002-12-11
BG62317B1 (bg) 1999-08-31
TW381024B (en) 2000-02-01
CA2122827A1 (fr) 1994-03-31
FI942272A0 (fi) 1994-05-16
EP0613372B1 (fr) 2000-12-27
DE69329790D1 (de) 2001-02-01
DZ1717A1 (fr) 2002-02-17
AU683423B2 (en) 1997-11-13
FR2695826A1 (fr) 1994-03-25

Similar Documents

Publication Publication Date Title
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
DK0680488T3 (da) 2,6-Diaminopurinderivater
EP1013660A4 (en) 2-FLUORFUCOSYL-N-AROYLGLUCOSAMINE DERIVATIVES, YOUR INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF
DZ1912A1 (fr) Hétéroaryl-oxazolidinones contenant de l'azote à 6members.
FR2669537B1 (fr) Composition amincissante a base d'alpha-2-bloqueurs.
DZ1835A1 (fr) Nouvelles formulations.
FR2695826B1 (fr) Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
FI930429A7 (fi) Uusia 1,4-dihydropyridiinijohdannaisia
FR2658536B1 (fr) Compositions et procedes d'electrodeposition.
FR2682679B1 (fr) Nouveaux derives d'alkylpolyosides, leurs procedes de preparation et applications comme agents de surface.
OA07147A (fr) Formulations d'aérosols à base aqueuse.
DZ1576A1 (fr) Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione.
FR2688118B1 (fr) Nouvelles compositions fongicides a base d'inhibiteurs de la biosynthese des sterols.
FR2665835B1 (fr) Nouvelles compositions pharmaceutiques a base de clozapine.
FI953784A7 (fi) 3'-atsiridinoantrasykliinijohdannaiset
FR2661830B1 (fr) Nouvelle compositions pharmaceutiques a base de flavonoside.
DE69122555D1 (de) 2,4-Dihydroxyadipinsäurederivate
BE890311A (fr) Nouvelles compositions pharmaceutiques a base d'un derive de la 1,4-dihydropyridine
FI960465A7 (fi) 15,15-dialkyylisubstituoituja estradiolin johdannaisia
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
FR2676224B1 (fr) Nouveaux sels d'ammonium quaternaire, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant.
FR2676364B1 (fr) Composition pharmaceutique a base de derives d'aminobutanone.
BR9408162A (pt) Derivados de ácido 2,3,5,6-tetrafluorbenzóico
ITMI921093A0 (it) Impianto di imbozzimatura dell'otdito
FI933872A7 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat